Nuvectra to Participate in Two Upcoming Investor Conferences
September 05 2018 - 4:01PM
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical
device company, announced today that Scott Drees, Chief Executive
Officer, and Walter Berger, Chief Operating Officer & Chief
Financial Officer, are scheduled to participate in two upcoming
investor conferences.
|
Event: |
Morgan
Stanley 16th Annual Global Healthcare Conference |
|
Date: |
Wednesday,
September 12, 2018 |
|
|
Location: |
The Grand
Hyatt, New York |
|
|
Format: |
1x1
Meetings |
|
|
|
Event: |
Cantor
Fitzgerald Global Healthcare Conference |
|
|
Date: |
Monday,
October 1, 2018 |
|
|
Time: |
4:40 p.m.
ET |
|
|
Location: |
InterContinental New York Barclay Hotel, New York |
|
Format: |
Presentation & 1x1 Meetings |
|
A webcast of the Company’s presentation at the Cantor Fitzgerald
Global Healthcare Conference will be available by visiting the
investor relations section of Nuvectra’s website at
www.nuvectramed.com. A webcast replay of the presentation will be
available for 90 days.
About Nuvectra Corporation
NuvectraTM is a neurostimulation company committed to helping
physicians improve the lives of people with chronic conditions. The
Algovita® Spinal Cord Stimulation (SCS) System is our first
commercial offering and is CE marked and FDA approved for the
treatment of chronic intractable pain of the trunk and/or limbs.
Our innovative technology platform also has capabilities under
development to support other indications such as sacral
neuromodulation (SNM) for the treatment of overactive bladder, and
deep brain stimulation (DBS) for the treatment of Parkinson’s
Disease. In addition, our NeuroNexus subsidiary designs,
manufactures and markets leading-edge neural-interface technologies
for the neuroscience clinical research market. Visit the Nuvectra
website at www.nuvectramed.com.
Company Contacts:
Nuvectra Corporation
Walter Berger, COO & CFO (214) 474-3102
wberger@nuvectramed.com
Investor Contacts:The Ruth Group
Tram Bui / Brian Johnston(646) 536-7035 / 7028
investors@nuvectramed.com
Nuvectra (NASDAQ:NVTR)
Historical Stock Chart
From May 2024 to Jun 2024
Nuvectra (NASDAQ:NVTR)
Historical Stock Chart
From Jun 2023 to Jun 2024